L-268-2016
Agreement ID
L-268-2016
Lead IC
NCI
Exclusivity
Exclusive
External Party
Kite Pharma, Inc.(Gilead Sciences, Inc.)
Fiscal Year
2016
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies